尿路结石成分对经皮肾镜取石术后发生急性肾损伤的影响

王碧霄, 宋海峰, 梁磊, 等. 尿路结石成分对经皮肾镜取石术后发生急性肾损伤的影响[J]. 临床泌尿外科杂志, 2023, 38(1): 42-47. doi: 10.13201/j.issn.1001-1420.2023.01.010
引用本文: 王碧霄, 宋海峰, 梁磊, 等. 尿路结石成分对经皮肾镜取石术后发生急性肾损伤的影响[J]. 临床泌尿外科杂志, 2023, 38(1): 42-47. doi: 10.13201/j.issn.1001-1420.2023.01.010
WANG Bixiao, SONG Haifeng, LIANG Lei, et al. Effect of urinary stone composition on acute kidney injury after percutaneous nephrolithotomy[J]. J Clin Urol, 2023, 38(1): 42-47. doi: 10.13201/j.issn.1001-1420.2023.01.010
Citation: WANG Bixiao, SONG Haifeng, LIANG Lei, et al. Effect of urinary stone composition on acute kidney injury after percutaneous nephrolithotomy[J]. J Clin Urol, 2023, 38(1): 42-47. doi: 10.13201/j.issn.1001-1420.2023.01.010

尿路结石成分对经皮肾镜取石术后发生急性肾损伤的影响

详细信息
    通讯作者: 李建兴,E-mail:ljx1@sina.com
  • 中图分类号: R693

Effect of urinary stone composition on acute kidney injury after percutaneous nephrolithotomy

More Information
  • 目的 评估经皮肾镜取石术(PCNL)后更容易发生急性肾损伤(AKI)的病例的临床特征,并探究各结石成分是否影响PCNL术后AKI的发生。方法 收集2016年3月—2022年1月北京清华长庚医院收治的483例PCNL治疗的尿路结石患者的临床资料,包括人口学相关参数、检验参数、结石特征参数、手术相关资料共4方面的数据,将所有患者根据是否发生术后AKI分成2组,计算整体AKI的发生率,并比较组间各临床因素的差异,并对组间差异有统计学意义的尿酸结石患者进行进一步各临床参数的亚组分析。结果 483例患者PCNL术后AKI的发生率为6.00%,与非AKI组患者比较,既往有结石病史、术前血清肌酐升高、术前血清尿酸增高、血清钙离子降低及结石成分为尿酸结石的患者PCNL术后发生AKI的可能性增高(P < 0.05)。72例尿酸结石患者PCNL术后AKI的发生率为12.50%,术后发生AKI与未发生AKI的尿酸结石患者比较,各临床参数差异均无统计学意义(P>0.05),但发生AKI的尿酸结石患者术前血清肌酐及尿酸水平略高,合并糖尿病及术前尿培养阳性的患者比例亦有增高。结论 本中心患者PCNL术后AKI的发生率为6.00%,尿酸结石患者术后AKI发生率可能增高,PCNL术后AKI还多见于既往有结石病史、术前血清肌酐、尿酸增高及钙离子降低的患者。
  • 加载中
  • 图 1  尿酸结石中AKI组和非AKI组间各计量资料的比较

    表 1  AKI组和非AKI组人口学相关各参数的比较  例(%),M(P25P75)

    参数 总体(483例) 非AKI组(454例) AKI组(29例) P 统计值
    年龄/岁 53.00(42.00,60.00) 53.00(42.00,60.00) 54.00(42.00,64.00) 0.411 0.676
    性别 0.043 4.098
        男 316(65.42) 292(64.32) 24(82.76)
        女 167(34.58) 162(35.68) 5(17.24)
    BMI/(kg·m-2) 25.04(22.88,27.74) 25.03(22.91,27.68) 25.16(21.72,28.73) 0.958 0.003
    结石病史 0.028 4.839
        无 136(28.16) 133(29.3) 3(10.34)
        有 347(71.84) 321(70.7) 26(89.66)
    合并髓质海绵肾 0.585 -
        无 469(97.10) 441(97.14) 28(96.55)
        有 14(2.90) 13(2.86) 1(3.45)
    合并马蹄肾 1.000 -
        无 464(96.07) 436(96.04) 28(96.55)
        有 19(3.93) 18(3.96) 1(3.45)
    合并脊柱畸形 0.430 -
        无 474(98.14) 446(98.24) 28(96.55)
        有 9(1.86) 8(1.76) 1(3.45)
    糖尿病 1.000 -
        无 403(83.44) 379(83.48) 24(82.76)
        有 80(16.56) 75(16.52) 5(17.24)
    高血压 0.641 0.218
        无 319(66.05) 301(66.3) 18(62.07)
        有 164(33.95) 153(33.7) 11(37.93)
    CKD 0.220 -
        无 479(99.17) 451(99.34) 28(96.55)
        有 4(0.83) 3(0.66) 1(3.45)
    痛风 0.267 -
        无 478(98.96) 450(99.12) 28(96.55) - -
        有 5(1.04) 4(0.88) 1(3.45) - -
    下载: 导出CSV

    表 2  AKI组和非AKI组检验资料各参数的比较  例(%),M(P25P75)

    参数 总体(483例) 非AKI组(454例) AKI组(29例) P 统计值
    术前尿培养     0.263 1.255
        阴性 313(64.80) 297(65.42) 16(55.17)
        阳性 170(35.20) 157(34.58) 13(44.83)
    术前血清肌酐/
    (μmol·L-1)
    72.80(61.85,89.85) 72.25(61.23,87.30) 97.60(74.80,153.20) < 0.001 17.928
    术后24 h内血清肌酐/
    (μmol·L-1)
    78.60(64.20,96.95) 77.00(63.85,93.62) 131.40(114.60,189.40) < 0.001 54.436
    术前HCT/% 40.70(37.10,44.60) 40.70(37.10,44.60) 40.80(36.10,44.10) 0.933 0.007
    术前血清尿酸/
    (μmol·L-1)
    357.00(300.00,438.50) 355.00(297.00,435.50) 398.00(343.00,481.00) 0.004 8.297
    术前血清钙离子/
    (mmol·L-1)
    2.24(2.18,2.31) 2.25(2.18,2.32) 2.20(2.13,2.25) 0.003 8.529
    下载: 导出CSV

    表 3  AKI组和非AKI组结石特征及手术相关资料各参数的比较  例(%),M(P25P75)

    参数 总体(483例) 非AKI组(454例) AKI组(29例) P 统计值
    术侧结石总直径/mm 28.00(20.00,40.00) 28.00(20.00,40.00) 33.00(20.00,40.00) 0.515 0.424
    术侧积水程度 0.440 -
        无 168(34.78) 155(34.14) 13(44.83)
        轻度 242(50.10) 230(50.66) 12(41.38)
        中度 64(13.25) 61(13.44) 3(10.34)
        重度 9(1.86) 8(1.76) 1(3.45)
    草酸钙结石 0.040 4.231
        否 165(34.16) 150(33.04) 15(51.72)
        是 318(65.84) 304(66.96) 14(48.28)
    鸟粪石 0.840 0.041
        否 390(80.75) 367(80.84) 23(79.31)
        是 93(19.25) 87(19.16) 6(20.69)
    尿酸石 0.026 -
        否 411(85.09) 391(86.12) 20(68.97)
        是 72(14.91) 63(13.88) 9(31.03)
    术前留置支架管/造瘘管 0.593 -
        无 413(85.51) 389(85.68) 24(82.76)
        有 70(14.49) 65(14.32) 5(17.24)
    手术时长/min 94.00(73.00,120.50) 94.00(72.00,120.00) 105.00(83.00,144.00) 0.062 3.478
    下载: 导出CSV

    表 4  AKI组和非AKI组各参数的单因素分析

    参数 OR(95%CI) P
    性别 0.376(0.141~1.003) 0.051
    结石病史 3.591(1.069~12.067) 0.039
    术前血清肌酐/
    (μmol·L-1)
    1.004(1.001~1.007) 0.009
    术前血清尿酸/
    (μmol·L-1)
    1.005(1.002~1.008) 0.001
    术前血清钙离子/
    (mmol·L-1)
    0.003(0~0.158) 0.004
    草酸钙结石 0.461(0.217~0.979) 0.044
    尿酸石 2.793(1.217~6.408) 0.015
    下载: 导出CSV

    表 5  尿酸结石中AKI组和非AKI组各参数的比较  例(%),M(P25P75)

    参数 尿酸结石非AKI组(63例) 尿酸结石AKI组(9例) P 统计值
    年龄/岁 55.00(49.00,62.50) 47.00(44.00,56.00) 0.173 1.858
    性别 0.679 -
        男 50(79.37) 8(88.89)
        女 13(20.63) 1(11.11)
    BMI/(kg·m-2) 26.04(23.82,29.36) 28.72(27.55,29.17) 0.072 3.227
    结石病史 1 -
        无 19(30.16) 2(22.22)
        有 44(69.84) 7(77.78)
    糖尿病 0.441 -
        无 45(71.43) 5(55.56)
        有 18(28.57) 4(44.44)
    高血压 0.494 -
        无 30(47.62) 3(33.33)
        有 33(52.38) 6(66.67)
    痛风 0.421 -
        无 60(95.24) 8(88.89)
        有 3(4.76) 1(11.11)
    术前尿培养 0.14 -
        阴性 41(65.08) 3(33.33)
        阳性 22(34.92) 6(66.67)
    术侧积水程度 0.082 -
        无 23(36.51) 5(55.56)
        轻度 34(53.97) 3(33.33)
        中度 6(9.52) 0(0)
        重度 0(0) 1(11.11)
    术前有无支架管 0.363 -
        无 52(82.54) 6(66.67)
        有 11(17.46) 3(33.33)
    手术侧结石总量/mm 30.00(22.50,41.50) 35.00(28.00,40.00) 0.805 0.061
    术前血清肌酐/(μmol·L-1) 83.30(72.50,125.80) 107.70(85.80,146.50) 0.090 2.870
    术后24 h内血清肌酐/(μmol·L-1) 93.10(81.65,123.70) 170.30(121.20,180.80) 0.002 9.762
    术前HCT/% 41.10(37.05,45.50) 43.40(40.70,44.10) 0.871 0.026
    术前血清尿酸/(μmol·L-1) 440.00(352.50,499.50) 481.00(473.00,582.00) 0.084 2.987
    术前血清钙离子/(mmol·L-1) 2.25(2.18,2.33) 2.18(2.15,2.25) 0.093 2.819
    手术时长/min 100.00(76.00,121.00) 112.00(105.00,150.00) 0.113 2.509
    下载: 导出CSV
  • [1]

    Verma S, Kellum JA. Defining Acute Kidney Injury[J]. Crit Care Clin, 2021, 37(2): 251-266. doi: 10.1016/j.ccc.2020.11.001

    [2]

    Liangos O, Wald R, O'Bell JW, et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey[J]. Clin J Am Soc Nephrol, 2006, 1(1): 43-51. doi: 10.2215/CJN.00220605

    [3]

    Ostermann M, Zarbock A, Goldstein S, et al. Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement[J]. JAMA Netw Open, 2020, 3(10): e2019209. doi: 10.1001/jamanetworkopen.2020.19209

    [4]

    李建兴, 肖博. 经皮肾镜取石术在肾结石治疗中的地位[J]. 临床外科杂志, 2017, 25(2): 89-90. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWK201702003.htm

    [5]

    Fulla J, Prasanchaimontri P, Wright HC, et al. Acute kidney injury and percutaneous nephrolithotomy: incidence and predictive factors[J]. World J Urol, 2022, 40(2): 563-567. doi: 10.1007/s00345-021-03874-4

    [6]

    Shi X, Peng Y, Li L, et al. Renal function changes after percutaneous nephrolithotomy in patients with renal calculi with a solitary kidney compared to bilateral kidneys[J]. BJU Int, 2018, 122(4): 633-638. doi: 10.1111/bju.14413

    [7]

    Yu J, Park HK, Kwon HJ, et al. Risk factors for acute kidney injury after percutaneous nephrolithotomy: Implications of intraoperative hypotension[J]. Medicine(Baltimore), 2018, 97(30): e11580.

    [8]

    Corrales M, Doizi S, Barghouthy Y, et al. Classification of Stones According to Michel Daudon: A Narrative Review[J]. Eur Urol Focus, 2021, 7(1): 13-21. doi: 10.1016/j.euf.2020.11.004

    [9]

    Patel PM, Kandabarow AM, Druck A, et al. Association of Impaired Renal Function With Changes in Urinary Mineral Excretion and Stone Composition[J]. Urology, 2020, 141: 45-49. doi: 10.1016/j.urology.2020.03.023

    [10]

    Li X, Wang LP, Ou LL, et al. Revolution spectral CT for urinary stone with a single/mixed composition in vivo: a large sample analysis[J]. World J Urol, 2021, 39(9): 3631-3642. doi: 10.1007/s00345-021-03597-6

    [11]

    Larcher L, Lefevre G, Bailleul S, et al. Importance of pre-analytical for urinalysis with urinary crystals. Dosages biochimiquesurinaires dans les urines présentant des cristaux: importance de la phase préanalytique[J]. Ann Biol Clin(Paris), 2017, 75(5): 525-530.

    [12]

    Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury[J]. Crit Care, 2007, 11(2): R31. doi: 10.1186/cc5713

    [13]

    Keller EX, De Coninck V, Audouin M, et al. Stone composition independently predicts stone size in 18, 029 spontaneously passed stones[J]. World J Urol, 2019, 37(11): 2493-2499. doi: 10.1007/s00345-018-02627-0

    [14]

    Tabibzadeh N, Zalc M, Michel T, et al. Prevalence and identification of crystalluria in critically ill patients: association between uric acid crystals and sepsis[J]. Clin Kidney J, 2020, 14(4): 1291-1293.

    [15]

    Caddeo G, Williams ST, McIntyre CW, et al. Acute kidney injury in urology patients: incidence, causes and outcomes[J]. Nephrourol Mon, 2013, 5(5): 955-961. doi: 10.5812/numonthly.12721

    [16]

    Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. Cost and Mortality Associated With Postoperative Acute Kidney Injury[J]. Ann Surg, 2015, 261(6): 1207-1214. doi: 10.1097/SLA.0000000000000732

    [17]

    Reeves T, Pietropaolo A, Gadzhiev N, et al. Role of Endourological Procedures(PCNL and URS)on Renal Function: a Systematic Review[J]. Curr Urol Rep, 2020, 21(5): 21. doi: 10.1007/s11934-020-00973-4

    [18]

    Hsu CY, Iribarren C, McCulloch CE, et al. Risk factors for end-stage renal disease: 25-year follow-up[J]. Arch Intern Med, 2009, 169(4): 342-350. doi: 10.1001/archinternmed.2008.605

    [19]

    Zhou F, Yu G, Wang G, et al. Association of serum uric acid levels with the incident of kidney disease and rapid eGFR decline in Chinese individuals with eGFR>60 mL/min/1.73 m2and negative proteinuria[J]. Clin Exp Nephrol, 2019, 23(7): 871-879. doi: 10.1007/s10157-019-01705-w

    [20]

    Su HY, Yang C, Liang D, et al. Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury[J]. Biomed Res Int, 2020, 2020: 5817348.

    [21]

    张勇, 陈站, 陈建刚, 等. 尿酸结石致病相关基因的研究进展[J]. 临床泌尿外科杂志, 2021, 36(2): 148-151. https://www.cnki.com.cn/Article/CJFDTOTAL-LCMW202102016.htm

    [22]

    Spatola L, Angelini C, Badalamenti S, et al. Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences[J]. Urolithiasis, 2017, 45(5): 457-460. doi: 10.1007/s00240-016-0956-8

    [23]

    Singh NP, Panwar V, Aggarwal NP, et al. Regulation of Calcium Homeostasis in Acute Kidney Injury: A Prospective Observational Study[J]. Indian J Crit Care Med, 2022, 26(3): 302-306. doi: 10.5005/jp-journals-10071-24124

    [24]

    Cheikh Hassan HI, Murali K, Lambert K, et al. Acute kidney injury increases risk of kidney stones-a retrospective propensity score matched cohort study[J]. Nephrol Dial Transplant, 2022.

  • 加载中

(1)

(5)

计量
  • 文章访问数:  1023
  • PDF下载数:  134
  • 施引文献:  0
出版历程
收稿日期:  2022-08-04
刊出日期:  2023-01-06

目录